BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17848406)

  • 1. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
    Shroff R; Kerchner A; Maifeld M; Van Beek EJ; Jagasia D; Dokras A
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
    González F; Minium J; Rote NS; Kirwan JP
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.
    Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.
    Escobar-Morreale HF; Botella-Carretero JI; Villuendas G; Sancho J; San Millán JL
    J Clin Endocrinol Metab; 2004 Feb; 89(2):806-11. PubMed ID: 14764799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Wijeyaratne CN; Nirantharakumar K; Balen AH; Barth JH; Sheriff R; Belchetz PE
    Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.